ES2535033T3 - Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida - Google Patents

Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida Download PDF

Info

Publication number
ES2535033T3
ES2535033T3 ES12199177.2T ES12199177T ES2535033T3 ES 2535033 T3 ES2535033 T3 ES 2535033T3 ES 12199177 T ES12199177 T ES 12199177T ES 2535033 T3 ES2535033 T3 ES 2535033T3
Authority
ES
Spain
Prior art keywords
dihydroxy
connectors
solid phase
oligomer synthesis
isoindole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES12199177.2T
Other languages
English (en)
Inventor
Ravikumar Vasulinga
Wang Zhiwei
Raju Krishna Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2535033T3 publication Critical patent/ES2535033T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula: **Fórmula** en la que R1 es arilo, cicloalquilo, cicloalquilo insaturado, alquilo, alquilo insaturado, heterociclilo, heterociclilo insaturado, heteroarilo o acilo, en la que R1 está opcionalmente sustituido con uno o más sustituyentes.

Description

28
ES12199177.2T 2003-11-13 2004-11-15 Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida Expired - Lifetime ES2535033T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US52017903P 2003-11-13 2003-11-13
US520179P 2003-11-13
US53047703P 2003-12-16 2003-12-16
US530477P 2003-12-16
US56464904P 2004-04-21 2004-04-21
US564649P 2004-04-21

Publications (1)

Publication Number Publication Date
ES2535033T3 true ES2535033T3 (es) 2015-05-04

Family

ID=34623783

Family Applications (2)

Application Number Title Priority Date Filing Date
ES12199177.2T Expired - Lifetime ES2535033T3 (es) 2003-11-13 2004-11-15 Derivados de 5,6 dihidroxi isoindol como conectores para la síntesis de oligómeros en fase sólida
ES04811142T Expired - Lifetime ES2403937T3 (es) 2003-11-13 2004-11-15 Derivados de 5,6-dihidroxi-isoindol como conectores para la síntesis de oligómeros en fase sólida

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES04811142T Expired - Lifetime ES2403937T3 (es) 2003-11-13 2004-11-15 Derivados de 5,6-dihidroxi-isoindol como conectores para la síntesis de oligómeros en fase sólida

Country Status (4)

Country Link
EP (2) EP2708541B1 (es)
DK (2) DK2708541T3 (es)
ES (2) ES2535033T3 (es)
WO (1) WO2005049621A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US7888324B2 (en) 2001-08-01 2011-02-15 Genzyme Corporation Antisense modulation of apolipoprotein B expression
EP2336318B1 (en) * 2002-11-13 2013-04-24 Genzyme Corporation Antisense modulation of apolipoprotein b expression
US7511131B2 (en) 2002-11-13 2009-03-31 Genzyme Corporation Antisense modulation of apolipoprotein B expression
US20050287558A1 (en) 2004-05-05 2005-12-29 Crooke Rosanne M SNPs of apolipoprotein B and modulation of their expression
DK2021472T3 (da) 2006-05-05 2011-09-19 Isis Pharmaceuticals Inc Forbindelser og fremgangsmåder til modulering af genekspression
RU2559536C2 (ru) 2007-03-24 2015-08-10 Джензим Корпорейшн Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в
US9107933B2 (en) 2009-03-16 2015-08-18 Isis Pharmaceuticals, Inc. Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III
JP5360763B2 (ja) 2009-10-21 2013-12-04 日東電工株式会社 核酸固相合成用リンカー及び担体
EP2620444B1 (en) * 2012-01-30 2015-05-06 Nitto Denko Corporation Linker and support for solid phase synthesis of nucleic acid
EP2666794A1 (en) 2012-05-23 2013-11-27 Nitto Denko Corporation Solid-phase support for oligonucleotide synthesis and oligonucleotide synthesis method
MY186570A (en) 2014-05-13 2021-07-27 Novartis Ag Compounds and compositions for inducing chondrogenesis
JP6537338B2 (ja) 2015-04-24 2019-07-03 日東電工株式会社 核酸固相合成用リンカー及び担体
EP3601310B1 (en) * 2017-03-29 2021-04-14 Roche Innovation Center Copenhagen A/S Unylinker rapid cleavage
AU2019235331A1 (en) 2018-03-14 2020-08-06 F. Hoffmann-La Roche Ag LNA-dicarboxylic acid derivatives and process for their preparation
TWI861602B (zh) * 2021-12-27 2024-11-11 財團法人工業技術研究院 化合物、包括其的固態載體以及製備核酸的方法
US20230203474A1 (en) * 2021-12-27 2023-06-29 Industrial Technology Research Institute Compound, solid carrier including the same and method for preparing nucleic acid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
USRE34069E (en) 1983-08-18 1992-09-15 Biosyntech Gmbh Process for the preparation of oligonucleotides
US5750666A (en) 1988-05-26 1998-05-12 Competitve Technologies, Inc. Polynucleotide phosphorodithioate compounds
DE68914843T2 (de) 1988-09-01 1994-11-10 Risoe Forskningscenter Peptid-synthese und fester träger zur verwendung dabei.
US6300486B1 (en) 1989-06-15 2001-10-09 Isis Pharmaceuticals, Inc. Large scale synthesis of oligonucleotides and their associated analogs
US5646265A (en) 1990-01-11 1997-07-08 Isis Pharmceuticals, Inc. Process for the preparation of 2'-O-alkyl purine phosphoramidites
US5166387A (en) 1990-01-12 1992-11-24 Applied Biosystems, Inc. Method of synthesizing sulfurized oligonucleotide analogs with thiuram disulfides
JP3231168B2 (ja) * 1992-12-22 2001-11-19 三井化学株式会社 感熱記録材料
US5391667A (en) 1993-03-04 1995-02-21 Isis Pharmaceuticals Copolymers of N-vinyl-lactams suitable for oligomer solid phase synthesis
US5614621A (en) 1993-07-29 1997-03-25 Isis Pharmaceuticals, Inc. Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents
US6001982A (en) 1993-07-29 1999-12-14 Isis Pharmaceuticals, Inc. Synthesis of oligonucleotides
US5889136A (en) 1995-06-09 1999-03-30 The Regents Of The University Of Colorado Orthoester protecting groups in RNA synthesis
US6476216B1 (en) 1995-10-20 2002-11-05 Mcgill University Preparation of phosphorothioate oligomers
US5734041A (en) 1995-10-20 1998-03-31 Mcgill University Preparation of chiral phosphorothioate oligomers
US5705621A (en) 1995-11-17 1998-01-06 Isis Pharmaceuticals, Inc. Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same
US6015895A (en) * 1995-12-22 2000-01-18 University Technologies International Inc. Linker arm for solid support oligonucleotide synthesis and process for production thereof
US6043353A (en) 1995-12-22 2000-03-28 University Technologies International, Inc. Reusable solid support for oligonucleotide synthesis, process for production thereof and process for use thereof
GB9612600D0 (en) 1996-06-13 1996-08-21 Ciba Geigy Ag Chemical compounds
US5955600A (en) 1996-12-27 1999-09-21 Isis Pharmaceuticals, Inc. Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
DE19811096A1 (de) 1997-04-30 1998-11-05 Schaeffler Waelzlager Ohg Synchronisiervorrichtung
US6114519A (en) 1997-10-15 2000-09-05 Isis Pharmaceuticals, Inc. Synthesis of sulfurized oligonucleotides
US6242591B1 (en) 1997-10-15 2001-06-05 Isis Pharmaceuticals, Inc. Synthesis of sulfurized 2'-substituted oligonucleotides
US6020475A (en) 1998-02-10 2000-02-01 Isis Pharmeuticals, Inc. Process for the synthesis of oligomeric compounds
US6111086A (en) 1998-02-27 2000-08-29 Scaringe; Stephen A. Orthoester protecting groups
US6274725B1 (en) 1998-06-02 2001-08-14 Isis Pharmaceuticals, Inc. Activators for oligonucleotide synthesis
US6335439B1 (en) 1998-06-11 2002-01-01 Isis Pharmaceuticals, Inc. Method of preparing phosphoramidites
US6465628B1 (en) 1999-02-04 2002-10-15 Isis Pharmaceuticals, Inc. Process for the synthesis of oligomeric compounds
US6147200A (en) 1999-08-19 2000-11-14 Isis Pharmaceuticals, Inc. 2'-O-acetamido modified monomers and oligomers
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040152905A1 (en) * 2003-01-31 2004-08-05 Guzaev Andrei P. Universal building blocks and support media for synthesis of oligonucleotides and their analogs
KR101595393B1 (ko) 2014-05-22 2016-02-18 엘지전자 주식회사 정보 제공 시스템 및 그 방법

Also Published As

Publication number Publication date
ES2403937T3 (es) 2013-05-22
DK1692139T3 (da) 2013-03-11
DK2708541T3 (en) 2015-02-23
EP2708541A1 (en) 2014-03-19
EP2708541B1 (en) 2015-01-28
EP1692139B1 (en) 2013-02-13
WO2005049621A1 (en) 2005-06-02
EP1692139A1 (en) 2006-08-23

Similar Documents

Publication Publication Date Title
CY1111493T1 (el) Παραγωγα πυραζολιου ως τροποποιητες πρωτεϊνοκινασης
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
CY1110489T1 (el) Παραγωγα ισοκινολινης
ES2308299T3 (es) Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas.
BR0113931A (pt) Compostos heterocìclicos ligantes receptores de quimiocinas
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
TN2011000286A1 (en) Spiroheterocyclic n-oxypiperidines as pesticides
CY1106486T1 (el) Μεθοδος παρασκευης 2-(κινοξαλιν-5-υλσουλφονυλαμινο) βενζαμιδικων ενωσεων
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
CR7076S (es) Recipiente
DE50311885D1 (de) Kohlenstoffhaltiges Material
EA200401398A1 (ru) Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы
TW200637853A (en) Fungicides
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
ECSP088684A (es) N-sulfonilacion selectiva de alcoholes 2-amino trifluoroalquilo sustituidos
EA201291376A1 (ru) Новые кальциевые соли соединения в качестве противовоспалительных, иммуномодулирующих и антипролиферативных агентов
TW200724528A (en) Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device
GB0423405D0 (en) Organic compounds
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
MX2021007505A (es) Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3.
BRPI0506927A (pt) compostos orgánicos
DK1706414T3 (da) Fremgangsmåde til fluorcytidinderivater
EA200400454A1 (ru) Мускариновые агонисты
AR040763A1 (es) Profarmacos de la (n-2- piridil-n-2- hidroxicarbonil-etil) - amida del acido 1- metil-2-(4-amidinofenilaminometil)-- benzimidazol-5-il-carboxilico, su preparacion y su utilizacion como medicamentos